

Cover Story
Free
By Matthew Bin Han Ong
Last August, Stephen A. Chagares, a breast surgeon, made an announcement that startled some of his colleagues at New Jersey’s Monmouth Medical Center. At internal meetings and in a press release, Chagares declared that he would perform a robotic mastectomy—a new and relatively untested minimally invasive surgical procedure. According to the press release, his first patient, Yvonne Zucco, 56, was being treated for stage IIa breast cancer.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned













